CANCER MAMMAIRE ET LA MUTATION BRCA1
| dc.contributor.author | BENATTIA, IMANE | |
| dc.contributor.author | BOUAZZA, NOUR EL HOUDA | |
| dc.date.accessioned | 2019-01-06T12:58:01Z | |
| dc.date.available | 2019-01-06T12:58:01Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | In Algeria, breast cancer is the most frequent malignant tumor and the leading cause of cancer death in women. It is a complex and heterogeneous disease. This heterogeneity is found at the histological, phenotypic and molecular level. It remains an ill-known disease and the current clinical and histological classifications do not allow to predict the prognostic and predictive parameters. The predisposition to breast cancer is inherited as a dominant trait.The presence of mutations with founding effect in the founding populations facilitates the discovery of highly penetrating alleles in high-risk individuals within families with a hereditary susceptibility to breast cancer. Our goal is to do a theoretical study on the mammary gland, demonstrated the importance of breast cancer and its relationship with the mutation BRCA1 | en_US |
| dc.identifier.uri | http://e-biblio.univ-mosta.dz/handle/123456789/8082 | |
| dc.language.iso | fr | en_US |
| dc.subject | Breast Gland | en_US |
| dc.subject | Breast Cancer | en_US |
| dc.subject | Mutation BRCA1 | en_US |
| dc.subject | Glande Mammaire | en_US |
| dc.subject | Cancer Mammaire | en_US |
| dc.subject | Mutation BRCA1 | en_US |
| dc.title | CANCER MAMMAIRE ET LA MUTATION BRCA1 | en_US |
| dc.type | Other | en_US |